113 related articles for article (PubMed ID: 7958387)
1. Protective action by hemin against interleukin-1 beta induced inhibition of rat pancreatic islet function.
Welsh N; Sandler S
Mol Cell Endocrinol; 1994 Jul; 103(1-2):109-14. PubMed ID: 7958387
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
Welsh N; Eizirik DL; Bendtzen K; Sandler S
Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
[TBL] [Abstract][Full Text] [Related]
3. A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1beta.
Ye J; Laychock SG
Endocrinology; 1998 Oct; 139(10):4155-63. PubMed ID: 9751495
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 beta induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets.
Welsh N; Sandler S
Biochem Biophys Res Commun; 1992 Jan; 182(1):333-40. PubMed ID: 1731791
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 4 impairs rat pancreatic islet function in vitro by an action different to that of interleukin 1.
Sandler S; Sternesjö J
Cytokine; 1995 Apr; 7(3):296-300. PubMed ID: 7640349
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-13 counteracts suppression induced by interleukin-1beta of glucose metabolism but not of insulin secretion in rat pancreatic islets.
Sternesjö J; Sandler S
Autoimmunity; 1997; 26(3):153-9. PubMed ID: 9550283
[TBL] [Abstract][Full Text] [Related]
7. Influence of protease on inhibitory and stimulatory effects of interleukin 1 beta on beta-cell function.
Welsh N; Bendtzen K; Sandler S
Diabetes; 1991 Feb; 40(2):290-4. PubMed ID: 1991576
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of fetal rat pancreatic beta-cell replication by interleukin-1 beta in vitro is not mediated through pertussis toxin-sensitive G-proteins, a decrease in cyclic AMP, or protease activation.
Sjöholm A
FEBS Lett; 1991 Sep; 289(2):249-52. PubMed ID: 1655527
[TBL] [Abstract][Full Text] [Related]
9. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
Corbett JA; McDaniel ML
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.
Corbett JA; Wang JL; Sweetland MA; Lancaster JR; McDaniel ML
J Clin Invest; 1992 Dec; 90(6):2384-91. PubMed ID: 1334975
[TBL] [Abstract][Full Text] [Related]
11. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
[TBL] [Abstract][Full Text] [Related]
13. Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice.
Sternesjö J; Sandler S
J Endocrinol; 1998 Jul; 158(1):69-75. PubMed ID: 9713328
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.
Rabuazzo AM; Buscema M; Caltabiano V; Anello M; Degano C; Patanè G; Vigneri R; Purrello F
Diabetologia; 1995 Jul; 38(7):779-84. PubMed ID: 7556978
[TBL] [Abstract][Full Text] [Related]
15. Succinic acid monomethyl ester protects rat pancreatic islet secretory potential against interleukin-1 beta (IL-1 beta) without affecting glutamate decarboxylase expression or nitric oxide production.
Eizirik DL; Welsh N; Niemann A; Velloso LA; Malaisse WJ
FEBS Lett; 1994 Jan; 337(3):298-302. PubMed ID: 8293819
[TBL] [Abstract][Full Text] [Related]
16. Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1 beta-induced dysfunction in cultured rat islets.
Bleich D; Chen S; Bursten SL; Nadler JL
Endocrinology; 1996 Nov; 137(11):4871-7. PubMed ID: 8895359
[TBL] [Abstract][Full Text] [Related]
17. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
[TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
[TBL] [Abstract][Full Text] [Related]
19. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets.
Eizirik DL; Welsh N; Hellerström C
J Clin Endocrinol Metab; 1993 Feb; 76(2):399-403. PubMed ID: 8432782
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
Sandler S; Bendtzen K; Eizirik DL; Welsh M
Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]